UNICA IRIS Institutional Research Information System

COLUMBANO, AMEDEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 244.830
NA - Nord America 10.963
AS - Asia 3.592
SA - Sud America 508
AF - Africa 55
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 4
Totale 259.973
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 241.009
US - Stati Uniti d'America 10.811
CN - Cina 1.571
SG - Singapore 1.328
NL - Olanda 1.082
UA - Ucraina 881
SE - Svezia 643
DE - Germania 428
BR - Brasile 421
FI - Finlandia 264
GB - Regno Unito 252
VN - Vietnam 213
CA - Canada 105
KR - Corea 94
FR - Francia 87
TR - Turchia 73
IN - India 68
HK - Hong Kong 42
AR - Argentina 33
JP - Giappone 33
RU - Federazione Russa 31
BD - Bangladesh 29
MX - Messico 28
PL - Polonia 27
ID - Indonesia 25
BE - Belgio 24
ES - Italia 23
IR - Iran 22
AU - Australia 20
ZA - Sudafrica 18
AT - Austria 16
MA - Marocco 15
VE - Venezuela 15
IQ - Iraq 14
PK - Pakistan 14
SA - Arabia Saudita 12
LT - Lituania 11
IE - Irlanda 10
PY - Paraguay 9
CO - Colombia 8
EC - Ecuador 8
IL - Israele 8
EG - Egitto 7
PE - Perù 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
AZ - Azerbaigian 5
BG - Bulgaria 5
JO - Giordania 5
RO - Romania 5
UZ - Uzbekistan 5
DZ - Algeria 4
EU - Europa 4
HN - Honduras 4
KZ - Kazakistan 4
MT - Malta 4
AL - Albania 3
CH - Svizzera 3
CL - Cile 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
PA - Panama 3
PT - Portogallo 3
TN - Tunisia 3
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
LK - Sri Lanka 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
BH - Bahrain 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
GT - Guatemala 1
IM - Isola di Man 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SC - Seychelles 1
SI - Slovenia 1
TW - Taiwan 1
Totale 259.973
Salva come PNG Salva come JPEG
Città #
Cagliari 236.761
Uta 3.758
Fairfield 1.293
Amsterdam 1.061
Ashburn 924
Woodbridge 854
Chandler 792
Singapore 633
Houston 613
Wilmington 530
Boardman 521
Ann Arbor 489
Seattle 488
Nyköping 471
Jacksonville 463
Cambridge 440
Dallas 365
Beijing 332
Dearborn 245
Los Angeles 198
Nanjing 153
Santa Clara 152
Boston 103
Helsinki 103
Hefei 92
Seoul 90
New York 89
Buffalo 83
Shanghai 79
San Diego 76
Guangzhou 69
Toronto 63
Ho Chi Minh City 59
The Dalles 59
Kocaeli 58
Shenyang 58
Nanchang 57
Redwood City 53
Hebei 51
Changsha 49
Falls Church 49
San Mateo 48
Mountain View 45
São Paulo 45
Milan 41
Munich 40
London 37
Dong Ket 36
Hong Kong 36
Jiaxing 36
Redondo Beach 36
Hanoi 33
Tianjin 32
Chicago 29
Jinan 28
Warsaw 26
Norwalk 25
Auburn Hills 24
Brussels 23
Atlanta 22
Brooklyn 22
Leawood 22
Augusta 21
Montreal 21
Orange 21
Tokyo 21
Phoenix 20
Rome 20
Turku 20
Verona 20
Stockholm 19
Millbury 18
Rio de Janeiro 18
Denver 17
Minneapolis 17
Nuremberg 17
Zhengzhou 17
Council Bluffs 15
Ardabil 14
Chennai 13
Casablanca 12
Columbus 12
Frankfurt am Main 12
Johannesburg 12
Ningbo 12
Washington 12
Monmouth Junction 11
Pune 11
Walnut 11
Wuhan 11
Curitiba 10
Dublin 10
Manchester 10
Porto Alegre 10
San Francisco 10
Biên Hòa 9
Da Nang 9
Detroit 9
Düsseldorf 9
Kilburn 9
Totale 254.102
Salva come PNG Salva come JPEG
Nome #
null 13.191
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 5.963
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 4.933
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 4.196
YAP activation is an early event and a potential therapeutic target in liver cancer development 3.984
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.913
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.820
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.698
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 3.666
Alpha-lipoic acid promotes the growth of rat hepatic preneoplastic lesions in the choline deficient model 3.664
Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells 3.620
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.613
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 3.548
Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor 3.536
Clustered protocadherins methylation alterations in cancer 3.277
Induction of hepatocyte proliferation by retinoic acid 3.276
Sex difference in the proliferative response of mouse hepatocytes to treatment with the CAR ligand TCPOBOP 3.203
The peroxisome proliferator BR931 kills FaO cells by p53-dependent apotosis 3.158
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 3.126
MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. 3.120
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.112
Potential utility of xenobiotic mitogens in the context of liver regeneration in the elderly and living-related transplantation 3.088
Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3) 3.081
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 3.023
The thyromimetic KB2115 (Eprotirome) induces rat hepatocyte proliferation 2.925
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 2.878
Regulatory effects of senescence marker protein 30 on the proliferation of hepatocytes 2.759
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.733
Progenitor-derived hepatocellular carcinoma model in the rat 2.693
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis 2.692
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.608
T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair 2.601
Timed regulation of P-element-induced wimpy testis-interacting RNA expression during rat liver regeneration 2.600
Estimation of a significance threshold for epigenome-wide association studies 2.550
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression 2.509
Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes 2.473
The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas 2.450
Induction of pancreatic acinar cell proliferation by thyroid hormone 2.433
Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis 2.404
null 2.399
Ciprofibrate and triiodothyronine do not suppress in vivo induction of placental glutathione S-transferase expression in rat hepatocytes 2.355
Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene 2.351
Reply to: Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: comparison in mice and humans 2.337
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.290
Gadd 45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia 2.286
Gadd45β is an inducible coactivator of transcription that facilitates rapid liver growth in mice 2.207
Proteomic characterization of early changes induced by triiodothyronine in rat liver 2.145
Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation 2.092
Triiodothyronine induces hepatocyte proliferation by protein kinase A-dependent-b-catenin activation in rodents. 2.088
Cell proliferation induced by 3,3',5 triiodo L thyronine is associated with a reduction in the number of preneoplastic hepatic lesions 2.086
DEXAMETHASONE INHIBITS INDUCTION OF LIVER-TUMOR NECROSIS FACTOR-ALPHA MESSENGER-RNA AND LIVER GROWTH INDUCED BY LEAD NITRATE AND ETHYLENE DIBROMIDE 2.049
Thyroid hormone receptor-β agonist induces β-catenin-dependent hepatocyte proliferation in mice: Implications in hepatic regeneration 1.938
AGING DOES NOT REDUCE THE HEPATOCYTE PROLIFERATIVE RESPONSE OF MICE TO THE PRIMARY MITOGEN TCPOBOP 1.896
METODO PER RILEVARE E/O PER LA PROGNOSI DI NEOPLASIE DEL COLON-RETTO 1.834
Different effects of regenerative and direct mitogenic stimuli on the growth of initiated cells in the resistant hepatocyte model 1.833
A large set of miRNAs is dysregulated from the earliest steps of human hepatocellular carcinoma development 1.820
Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis 1.784
miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling 1.770
Dexametasone inhibits induction of liver Tumor Necrosis Factor-a mRNA and liver growth induced by lead nitrate and ethylene dibromide 1.750
Different effects of the liver mitogens triiodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma 1.749
Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas 1.728
The dual roles of NRF2 in cancer 1.704
Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular Cancer 1.697
Loss of cyclin D1 does not inhibit the proliferative response of mouse liver to mitogenic stimuli 1.668
Increased expression of c.fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP 1.664
Differential effects of choline administration on liver microsomes of female and male rats 1.630
Peroxisome proliferator-activated receptor-alpha(-/-) mice show enhanced hepatocyte proliferation in response to the hepatomitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene, a ligand of constitutive androstane receptor 1.626
Differences in the steady-state levels of c-fos, c-jun and c-myc messanger RNA during mitogen-induced liver growth and compensatory regeneration 1.611
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 1.610
Constitutive androstane receptor (Car)-driven regeneration protects liver from failure following tissue loss 1.605
Studies on the kinetics of expression of cell cycle dependent proto-oncogenes during mitogen-induced liver cell proliferation 1.555
MicroRNA: New Tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? 1.539
Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of trascription factors NF-kB and AP-1 or expression of tumor necrosis factor-alfa 1.478
Met as a therapeutic target in HCC: Facts and hopes 1.433
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 1.413
An electron microscopic study of apoptosis induced by cycloheximide in rat liver 1.393
A common set of immediate-early response genes in liver regeneration and hyperplasia 1.373
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 1.177
Mitogenesis by ligands of nuclear receptors: an attractive model for the study of the molecular mechanisms implicated in liver growth 1.157
Early ultrastructural changes during thioacetamide-induced apoptosis in rat liver 1.152
Genome-wide single nucleotide polymorphysm analysis of lung cancer risk detects the KLF6 gen 1.082
The TRbeta-selective agonist, GC-1, stimulates mitochondrial oxidative processes to a lesser extent than triiodothyronine 1.034
null 951
Hexose monophosphate shunt and cholesterogenesis in lead-induced kidney hyperplasia 932
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 911
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 908
HMP-shunt and cholesterol metabolism in experimental models involving normal and preneoplastic liver growth. 867
Stimulation of DNA synthesis after a single administration of cadmium nitrate. 861
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 851
Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate 849
Cell proliferation in rat kidney induced by 1,2-dibromoethane 844
T3 and the thyroid hormone beta-receptor agonist GC-1 differentially affect metabolic capacity and oxidative damage in rat tissues 842
Induction of 2 different modes of cell-death, apoptosis and necrosis, in rat-liver after a single dose of thioacetamide 841
Liver hyperplasia is not necessarily associated with increased expression of c-fos and c-myc mRNA 837
Occurence of cell death (Apoptosis) during the involution of liver hyperplasia 837
Induction of cellular DNA synthesis in the pancreas and kidneys of rats by peroxisome proliferators, 9-cis retinoic acid, and 3,3',5-triiodo-L-thyronine 836
Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens 826
Cell deletion by apoptosis during regression of renal hyperplasia. 810
Liver hyperplasia and regression after lead nitrate administration 809
Effects of cell proliferation and cell death (apoptosis and necrosis) on the early stages of rat hepatocarcinogenesis 785
Totale 226.902
Salva come PNG Salva come JPEG
Categoria #
all - tutte 324.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 324.282
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124.903 0 0 0 0 0 6.752 5.396 3.982 1.408 2.878 2.957 1.530
2021/202213.864 1.847 1.210 687 919 1.129 1.048 748 561 1.468 1.236 1.423 1.588
2022/202319.224 1.491 2.529 2.506 1.704 1.674 1.833 994 1.502 1.175 1.324 1.568 924
2023/202419.982 1.380 925 1.896 1.415 1.808 2.537 2.702 1.442 910 1.379 1.788 1.800
2024/202530.988 7.855 8.128 3.496 3.015 1.668 2.020 2.223 180 336 1.351 299 417
2025/20264.186 598 577 937 898 816 360 0 0 0 0 0 0
Totale 260.340